Laboratory Tests for Investigating Thrombocytopenia
The initial laboratory evaluation of thrombocytopenia should include a complete blood count with peripheral blood smear examination, coagulation studies, and targeted testing based on clinical presentation to determine the underlying cause. 1
First-Line Laboratory Tests
- Complete blood count (CBC) to confirm thrombocytopenia and evaluate other cell lines for concurrent abnormalities 1, 2
- Peripheral blood smear examination to assess platelet morphology, size variations, and exclude pseudothrombocytopenia due to EDTA-dependent platelet agglutination 1
- Prothrombin time (PT) and activated partial thromboplastin time (aPTT) to evaluate for coagulation disorders 2
- Reticulocyte count to assess for bone marrow response and potential hemolysis 3
Second-Line Laboratory Tests
Immune-Mediated Thrombocytopenia Evaluation
- HIV and HCV serologic testing regardless of risk factors, as these infections can cause thrombocytopenia indistinguishable from primary ITP 1
- Helicobacter pylori testing (urea breath test or stool antigen test preferred) in adults with typical ITP 1
- Blood group Rh(D) typing if anti-D immunoglobulin therapy is being considered 1
- Drug-dependent platelet antibody testing for suspected drug-induced immune thrombocytopenia (DITP), using serum or citrate samples (avoid EDTA) 1
Bone Marrow Assessment
- Bone marrow examination (aspirate and biopsy) with flow cytometry and cytogenetic testing in patients over 60 years, those with systemic symptoms, abnormal signs, or when splenectomy is considered 1
Additional Testing Based on Clinical Presentation
- LDH, haptoglobin, and indirect bilirubin to assess for hemolysis 3
- Direct Coombs test to rule out immune-mediated hemolysis 3
- Serum creatinine, BUN, and electrolytes to evaluate renal function 3
- Liver function tests to assess for hepatic disease 2, 4
- Antiphospholipid antibodies (not routine, but indicated if symptoms of antiphospholipid syndrome are present) 1
Specialized Testing for Specific Conditions
For Suspected Inherited Platelet Function Disorders
- Light transmission aggregometry (LTA) using epinephrine, ADP, collagen, arachidonic acid, and ristocetin 1
- Flow cytometry to assess platelet surface glycoproteins (GPIIb/IIIa, GPIIIa, GPIb, GPIb/IX) 1, 5
- Granule release assays to evaluate α-granule and δ-granule secretion 1, 5
For Suspected Thrombotic Microangiopathies
- ADAMTS13 activity for suspected thrombotic thrombocytopenic purpura (TTP) 3
- Complement studies for suspected atypical hemolytic uremic syndrome (aHUS) 3
Tests of Limited Utility
- Antiplatelet antibody assays are not routinely recommended as platelet-associated IgG is elevated in both immune and non-immune thrombocytopenia 1
- Antinuclear antibody (ANA) testing has limited utility unless systemic lupus erythematosus is suspected 1
Important Considerations
- Collect blood samples for drug-dependent antibody testing during acute thrombocytopenia or within 3 weeks of the event 1
- Avoid EDTA tubes for platelet antibody testing as it can cause glycoprotein complex dissociation 1
- When pseudothrombocytopenia is suspected, collect blood in tubes containing heparin or sodium citrate and repeat the platelet count 2
- Distinguish between acute and chronic thrombocytopenia by reviewing previous platelet counts 2
Clinical Pitfalls to Avoid
- Don't assume all isolated thrombocytopenias are immune thrombocytopenia without appropriate exclusion of other causes 2, 4
- Don't delay evaluation of severe thrombocytopenia (<10 × 10³/μL) as it constitutes a hematologic emergency with high risk of serious bleeding 2, 4
- Remember that some conditions like heparin-induced thrombocytopenia, antiphospholipid syndrome, and thrombotic microangiopathies can present with both thrombocytopenia and thrombosis 2